Does controlled ovarian hyperstimulation in women with a history of borderline tumor influence recurrence rate?

Han Gao, Ning Wang(Guangdong Academy of Medical Sciences), Wei Wei(Zhujiang Hospital), Yibing Li(Second Affiliated Hospital of Dalian Medical University)
Research Square
December 7, 2022
10.21203/rs.3.rs-2292545/v1
Cited by 0

Related Papers

Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
|JAMA Oncology|2019|559
Adult intussusception: A retrospective review of 41 cases
|World Journal of Gastroenterology|2009|287
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
|Journal of Clinical Oncology|2020|217
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma
|Therapeutic Advances in Medical Oncology|2021|216
Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety
|癌症：英文版|2018|189